Live Breaking News & Updates on மாற்றாந்தாய் கண்டுபிடிப்பு
Stay updated with breaking news from மாற்றாந்தாய் கண்டுபிடிப்பு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As the Afghan government fights for its very survival, the question is whether the Taliban’s momentum is now so strong the collapse of the government becomes…
Netizen Voices: Hu Xijin’s Taliban Friendship Comments Criticized Posted by Joseph Brouwer | Jul 12, 2021 A Taliban spokesperson’s claim that China is a “friend” incited an online furore after nationalist Chinese media figures shared the statement approvingly. “We have been to China many times and we have good relations with them,” the Taliban spokesperson said, adding that “China is a friendly country that we welcome for reconstruction and developing Afghanistan.” Guancha, a nationalist website financed by the venture capitalist Eric X. Li, published a report on the spokesperson’s statements. Hu Xijin, the editor-in-chief of Global Times, shared Guancha’s article on Weibo as an example of China’s diplomatic prowess: “China’s line has made us Kabul’s friend, while the Taliban also take us for friends. The most important thing is we will forever be Afghanistan’s friends.”
Indian vaccine makers decry US use of wartime powers to protect supplies timeslive.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timeslive.co.za Daily Mail and Mail on Sunday newspapers.
Home Russia’s Covid vaccine faces global production hurdles Russia’s Covid vaccine faces global production hurdles Moscow has entrusted future of Sputnik V jab to sprawling network of private companies around world World Economy News 17 Feb 2021 • 5 min read A global network of private factories that Russia is relying on to supply its Sputnik V coronavirus vaccine to international markets is months away from reaching full production levels, raising doubts over Moscow’s ability to honour dozens of agreements with foreign countries. The Kremlin funded the development of Sputnik V but lacks the production capacity to make enough of it, meaning Russia must now depend on factories in Brazil, India and South Korea if it is going to meet a target of vaccinating almost one-tenth of the world’s population.
Vaccines vs variants: the race to immunise the developing world Spread of new Covid strains has made it even more urgent to launch rapid vaccination drives in poorer countries 11 February 2021 - 21:49 By David Pilling, Stephanie Findlay and Bryan Harris On a balmy day in January on the outskirts of Pune, a city of three million people in Maharashtra state, women in saris are sitting on plastic chairs under a humming fan waiting for their first shot of Covishield as the Oxford/AstraZeneca Covid-19 vaccine is known in India. Wearing a white doctor’s coat, Dr Varsha Gaekwad, who is overseeing the first immunisations of frontline healthcare workers in the country of nearly 1.4 billion people, says it will take time for the general public to gain confidence in the vaccine. “Once the health workers are going ahead with it, that means it’s 100% safe,” she says. “That is what the community will see.”..
India Has Gained Two Vaccines but Its Regulators Have Tarnished Indian Science 06/01/2021 Photo: manicomi/Flickr, CC BY 2.0. In mid-December 2020, when British foreign secretary Dominic Raab visited India, he made it a point to highlight India’s vital role in the international response to the COVID-19 pandemic. India, he noted, supplied more than 50% of the world’s vaccines, and 25% of the generic drugs used in the UK’s £120-billion-a-year National Health Service. A week, it is said, is a long time in politics, and in the fortnight since that visit, much has happened. The British prime minister’s visit to India, that Raab was preparing the ground for, stands cancelled, and a media storm has swirled around the hasty and allegedly premature approval by Indian regulators of the vaccine candidates developed by two of India’s leading bio-pharma manufacturers: the Serum Institute in Pune and Bharat Biotech in Hyderabad.
France, which has close links with its former colonies in west Africa, Ms Touraine said the country’s health service was prepared to tackle the threat. Frontières warned of an “epidemic out of control”, Ms Touraine told the newspaper Le Parisien there was little risk of it spreading to France. “At the moment, the risk of the virus coming to Europe or to France is low,” Ms Touraine insisted. “We are taking steps so that our country won’t be affected.” “prevention”. know how to diagnose and deal with any patient suffering from fever who has just returned from one of the countries affected by the epidemic,” she said.